B. Riley Wealth Advisors, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 183 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$55,000
-50.5%
31,685
+2.8%
0.00%
-50.0%
Q1 2022$111,000
-43.4%
30,815
-21.4%
0.00%
-33.3%
Q4 2021$196,000
-33.8%
39,207
-4.9%
0.01%
-33.3%
Q3 2021$296,000
-31.5%
41,220
-11.5%
0.01%
-35.7%
Q2 2021$432,000
-38.0%
46,570
-37.9%
0.01%
-44.0%
Q1 2021$697,000
+79.6%
75,011
+71.3%
0.02%
+19.0%
Q4 2020$388,000
+70.9%
43,780
+148.0%
0.02%
+75.0%
Q3 2020$227,000
-37.1%
17,653
+32.0%
0.01%
-50.0%
Q2 2020$361,000
-86.6%
13,376
+5250.4%
0.02%
+2300.0%
Q2 2014$2,703,0002500.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders